NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,854,658 | -15.9% | 424,437 | +116.0% | 0.08% | -3.8% |
| Q2 2023 | $8,154,543 | -57.8% | 196,495 | -38.8% | 0.08% | -61.0% |
| Q1 2023 | $19,303,196 | -23.1% | 320,971 | -6.2% | 0.20% | -26.7% |
| Q4 2022 | $25,101,104 | -5.7% | 342,210 | -2.3% | 0.27% | -12.5% |
| Q3 2022 | $26,614,000 | +7.8% | 350,271 | -1.4% | 0.31% | +9.9% |
| Q2 2022 | $24,687,000 | -40.9% | 355,214 | -29.6% | 0.28% | -24.9% |
| Q1 2022 | $41,786,000 | +28.4% | 504,354 | +16.4% | 0.38% | +47.1% |
| Q4 2021 | $32,531,000 | +23.5% | 433,284 | +91.1% | 0.26% | +24.2% |
| Q3 2021 | $26,344,000 | -66.9% | 226,767 | -36.9% | 0.21% | -64.6% |
| Q2 2021 | $79,692,000 | +20653.1% | 359,266 | +12279.9% | 0.58% | +19366.7% |
| Q1 2021 | $384,000 | -97.7% | 2,902 | -98.1% | 0.00% | -97.9% |
| Q3 2020 | $16,735,000 | +1229.2% | 150,350 | +608.3% | 0.15% | +1227.3% |
| Q2 2020 | $1,259,000 | -89.1% | 21,227 | -87.6% | 0.01% | -91.5% |
| Q1 2020 | $11,533,000 | +250.4% | 171,258 | +338.5% | 0.13% | +441.7% |
| Q4 2019 | $3,291,000 | -13.7% | 39,056 | -23.4% | 0.02% | -20.0% |
| Q3 2019 | $3,813,000 | -85.2% | 50,995 | -87.5% | 0.03% | -84.5% |
| Q2 2019 | $25,724,000 | +45.9% | 406,833 | +11.2% | 0.19% | +55.2% |
| Q1 2019 | $17,631,000 | +52.3% | 366,010 | +5.9% | 0.12% | +34.4% |
| Q4 2018 | $11,575,000 | +116.9% | 345,726 | +239.5% | 0.09% | +173.5% |
| Q3 2018 | $5,336,000 | -52.1% | 101,823 | -71.4% | 0.03% | -57.0% |
| Q2 2018 | $11,142,000 | -53.9% | 355,967 | -67.9% | 0.08% | -55.1% |
| Q1 2018 | $24,152,000 | +10.5% | 1,107,899 | +2.4% | 0.18% | +10.0% |
| Q4 2017 | $21,854,000 | +32.1% | 1,081,898 | +29.8% | 0.16% | +34.5% |
| Q3 2017 | $16,546,000 | +15.6% | 833,576 | +0.8% | 0.12% | +14.4% |
| Q2 2017 | $14,308,000 | – | 827,054 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |